Unfolding intermediates of the extracellular domain of the interferon gamma receptor.

Reduction of proteins which require disulfide bonds to be stable in the folded state is accompanied by step-wise unfolding. A soluble human interferon gamma receptor produced in Escherichia coli was used to investigate the kinetics of formation of unfolding intermediates. The protein includes 8 cysteine residues forming four disulfide bonds. It was reduced by using either dithiothreitol or the thioredoxin reduction system. Reduction with dithiothreitol resulted in formation of mainly four monomeric unfolding species as visualized by sodium dodecyl sulfate-polyacrylamide gels. The enzymatically catalyzed reaction produced only small amounts of two monomeric products and mostly delivered oligomeric and polymeric forms. In both cases, the ligand binding capacity of the receptor was significantly reduced immediately after appearance of the first intermediate. The intermediates involved interchange of disulfide bonds and did not show ligand binding capacity. Some of them were recognized by specific antibodies which detect conformational epitopes on the native interferon gamma receptor. On the basis of the antibody binding, a preliminary characterization of the formed intermediates was attempted. When the soluble receptor was reduced in the presence of denaturing agents, the reduction products were different from the unfolding intermediates generated in the absence of denaturants.

• Publication year

  1992

• Venue

  Journal of Biological Chemistry

• Publication date

  1992-04-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0021-9258(19)50542-7PMID 1372607
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thioredoxin and glutaredoxin systems.

  2019cited by this paper
• Folding and association of proteins

  2004cited by this paper
• A 25-kDa stretch of the extracellular domain of the human interferon gamma receptor is required for full ligand binding capacity.

  1991cited by this paper
• An analysis of protein folding pathways.

  1991cited by this paper
• A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme.

  1991cited by this paper
• Protein folding: local structures, domains, subunits, and assemblies.

  1991cited by this paper
• The mechanism of protein folding. Implications of in vitro refolding models for de novo protein folding and translocation in the cell.

  1990cited by this paper
• Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity.

  1990cited by this paper
• Intermediates in the folding reactions of small proteins.

  1990cited by this paper
• Purification and biochemical characterization of a soluble human interferon gamma receptor expressed in Escherichia coli.

  1990cited by this paper
• Transient folding intermediates characterized by protein engineering

  1990cited by this paper
• Protein sorting to mitochondria: evolutionary conservations of folding and assembly.

  1990cited by this paper
• Molecular Chaperones: The Plant Connection

  1990cited by this paper
• Human interferon-gamma receptor. Mapping of epitopes recognized by neutralizing antibodies using native and recombinant receptor proteins.

  1990cited by this paper
• Structure and membrane topology of the high-affinity receptor for human IFN-gamma: requirements for binding IFN-gamma. One single 90-kilodalton IFN-gamma receptor can lead to multiple cross-linked products and isolated proteins.

  1989cited by this paper
• Mutational analysis of a protein-folding pathway

  1989cited by this paper
• Conformation of peptide fragments of proteins in aqueous solution: implications for initiation of protein folding.

  1988cited by this paper
• Genetic studies of protein stability and mechanisms of folding.

  1988cited by this paper
• Toward a better understanding of protein folding pathways.

  1988cited by this paper
• A peptide model of a protein folding intermediate

  1988cited by this paper
• Thioredoxin.

  1985cited by this paper
• Disulfide bond formation in proteins.

  1984cited by this paper
• Specific intermediates in the folding reactions of small proteins and the mechanism of protein folding.

  1982cited by this paper
• Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein.

  1981cited by this paper
• Intermediates in the refolding of reduced ribonuclease A.

  1979cited by this paper
• Effects of urea and guanidine-HCl on the folding and unfolding of pancreatic trypsin inhibitor.

  1977cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• DITHIOTHREITOL, A NEW PROTECTIVE REAGENT FOR SH GROUPS.

  1964cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper

• Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro

  2007cites this paper
• Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells.

  2000cites this paper
• cells Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia

  2000cites this paper
• Parallel syntheses of disulfide inhibitors of the thioredoxin redox system as potential antitumor agents.

  1999cites this paper
• Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides.

  1998cites this paper
• Production and secretion of thioredoxin from transformed human trophoblast cells.

  1998cites this paper
• Modulation of the antioxidant defense during dexamethasone-induced apoptosis in WEHI7.2 mouse lymphoid cells

  1997cites this paper
• Redox signaling and the control of cell growth and death.

  1997cites this paper
• Studies of the Nature of the Binding by Albumin of Platelet-activating Factor Released from Cells*

  1997cites this paper
• Potential mechanisms for apoptosis induced by both the NSAIDs and thioredoxin, including inhibition of the transcription factor NF-κB

  1997cites this paper
• Modification of the Laemmli sodium dodecyl sulfate-polyacrylamide gel electrophoresis procedure to eliminate artifacts on reducing and nonreducing gels.

  1997cites this paper
• Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73-->Ser mutation.

  1996cites this paper
• Apparent heterogeneity of recombinant interferon gamma receptors produced in prokaryotic and eukaryotic expression systems.

  1996cites this paper
• Interferon gamma receptor extracellular domain expressed as IgG fusion protein in Chinese hamster ovary cells. Purification, biochemical characterization, and stoichiometry of binding.

  1995cites this paper
• Immunocytochemical localization of thioredoxin in human trophoblast and decidua.

  1995cites this paper
• Dissection of the extracellular human interferon gamma receptor alpha-chain into two immunoglobulin-like domains. Production in an Escherichia coli thioredoxin gene fusion expression system and recognition by neutralizing antibodies.

  1995cites this paper
• Phosphoric Acid Entrapment Leads to Apparent Protein Heterogeneity

  1995cites this paper
• Interferon γ Receptor Extracellular Domain Expressed as IgG Fusion Protein in Chinese Hamster Ovary Cells

  1995cites this paper
• Redox signalling and the control of cell growth and death.

  1995cites this paper
• Occurs by a Novel Helper Mechanism

  1995cites this paper
• Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism.

  1995cites this paper
• The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors.

  1994cites this paper
• Alignment of disulfide bonds of the extracellular domain of the interferon gamma receptor and investigation of their role in biological activity.

  1993cites this paper
• Effect of Glycosylation on Properties of Soluble Interferon Gamma Receptors Produced in Prokaryotic and Eukaryotic Experession Systems

  1992cites this paper